Used in pharmaceutical research as a key intermediate in the development of antimalarial agents. Its structure supports activity against chloroquine-resistant strains of Plasmodium by targeting heme detoxification pathways in the parasite. Also investigated for anti-inflammatory and anticancer properties due to its ability to modulate cellular signaling pathways. Shows potential in structure-activity relationship (SAR) studies for optimizing drug candidates with improved efficacy and reduced toxicity.